Robert Stone

Robert Stone

Alston & Bird

Contact

Readers' Choice Awards

Healthcare
Healthcare
View Bio
RSS

Latest Posts › Department of Health and Human Services (HHS)

Share:

Health Care Week In Review: HHS Final Rule and President Biden Executive Order

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

4/24/2023  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Mental Health , National Institute of Health (NIH) , Popular , Reproductive Healthcare Issues , SAMHSA

Health Care Week In Review: CMS and HHS Issue Proposed Rules

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

4/17/2023  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Health Insurance Portability and Accountability Act (HIPAA) , Inpatient Prospective Payment System (IPPS) , Medicare , National Institute of Health (NIH) , Popular

Health Care Week in Review: CMS Issues Proposed and Final Rules and NIH Releases a Cancer Plan

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

4/10/2023  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Medicaid , Medicare , National Institute of Health (NIH) , SAMHSA

Health Care Week in Review: Senate Votes to End COVID-19 National Emergency, CMS Releases Rate Notice

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

4/3/2023  /  Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Medical Devices , Medicare , Popular , Public Health Emergency

Health Care Week in Review: Health Care Budget Hearings and Organ System Modernization

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

3/27/2023  /  Centers for Disease Control and Prevention (CDC) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Medicaid , Medicare , SAMHSA

Health Care Week in Review: President’s Budget and ASPR Cybersecurity Guide

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

3/13/2023  /  Centers for Disease Control and Prevention (CDC) , Coronavirus/COVID-19 , Cybersecurity , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , HRSA , National Institute of Health (NIH) , Popular , Public Health , Public Health Emergency

Health Care Week in Review: DEA Issues Proposed Rules on Controlled Substances Prescribing via Telemedicine

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

3/7/2023  /  Controlled Substances , DEA , Department of Health and Human Services (HHS) , Electronic Prescribing , Food and Drug Administration (FDA) , Health Care Providers , HRSA , National Institute of Health (NIH) , Pharmaceutical Industry , Prescription Drugs , Telehealth , Telemedicine

Health Care Week in Review: FY 2024 Appropriations Process Begins

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

2/27/2023  /  Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Hospitals , Medicaid , Medicare , National Institute of Health (NIH) , SAMHSA

Health Care Week in Review: CMMI Announces Three New Models, President Biden Issues Executive Order

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

2/20/2023  /  Abbreviated New Drug Application (ANDA) , Affordable Care Act , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Medicaid , Medicare , National Institute of Health (NIH) , Pharmaceutical Industry

Health Care Week in Review: State of the Union and HHS Guidance on Drug Rebates and PHE

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

2/13/2023  /  Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Medicaid , Medical Devices , Medicare , National Institute of Health (NIH) , Pharmaceutical Industry , Prescription Drugs , Public Health Emergency , Vaccinations

Health Care Week in Review: Biden Administration Plans to End COVID-19 PHE on May 11

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

2/7/2023  /  Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Medical Devices , Medicare , Public Health Emergency

HHS Announces $20 Billion Phase 3 General Distribution

Our Health Care Group reviews the nuances for eligibility and applying for the latest round of COVID-19 relief from the CARES Act’s Provider Relief Fund....more

10/5/2020  /  CARES Act , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Health Care Providers , HRSA , Provider Relief Fund , Reporting Requirements

CMS Issues Blanket Waivers from Physician Self-Referral Law Sanctions

Our Health Care Group dives into the Centers for Medicare & Medicaid Services’ Stark Law waivers for physicians and hospitals fighting the coronavirus (COVID-19) pandemic. - COVID-19 Purpose and 18 blanket waivers...more

4/2/2020  /  Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Stark Law , Waivers
113 Results
 / 
View per page
« Previous
Page: of 5

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide